Takip et
Collins Iwuji
Collins Iwuji
Department of Global Health & Infection, Brighton & Sussex Medical School, UK
bsms.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Alıntı yapanlar
Alıntı yapanlar
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
CC Iwuji, J Orne-Gliemann, J Larmarange, E Balestre, R Thiebaut, ...
The lancet HIV 5 (3), e116-e125, 2018
Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS …
CC Iwuji, J Orne-Gliemann, J Larmarange, N Okesola, F Tanser, ...
PLoS medicine 13 (8), e1002107, 2016
Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial …
CC Iwuji, J Orne-Gliemann, F Tanser, S Boyer, RJ Lessells, F Lert, J Imrie, ...
Trials 14 (1), 1-15, 2013
Access to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster‐randomized trial in rural South Africa
M Plazy, KE Farouki, C Iwuji, N Okesola, J Orne‐Gliemann, J Larmarange, ...
Journal of the International AIDS Society 19 (1), 20913, 2016
Older HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study
CC Iwuji, D Churchill, Y Gilleece, HA Weiss, M Fisher
BMC public health 13 (1), 1-9, 2013
The impact of universal test and treat on HIV incidence in a rural South African population: ANRS 12249 TasP trial, 2012–2016
C Iwuji, J Orne-Gliemann, E Balestre, J Larmarange, R Thiebaut, F Tanser, ...
AIDS Conference, 18-22, 2016
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
D Havlir, S Lockman, H Ayles, J Larmarange, G Chamie, T Gaolathe, ...
Journal of the International AIDS Society 23 (2), e25455, 2020
Access to primary healthcare during lockdown measures for COVID-19 in rural South Africa: an interrupted time series analysis
MJ Siedner, JD Kraemer, MJ Meyer, G Harling, T Mngomezulu, P Gabela, ...
BMJ open 10 (10), e043763, 2020
Linkage to HIV care after home‐based HIV counselling and testing in sub‐Saharan Africa: a systematic review
E Ruzagira, K Baisley, A Kamali, S Biraro, H Grosskurth, ...
Tropical medicine & international health 22 (7), 807-821, 2017
Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the …
S Boyer, C Iwuji, A Gosset, C Protopopescu, N Okesola, M Plazy, B Spire, ...
AIDS care 28 (sup3), 39-51, 2016
Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria
RJ Lessells, PC Mutevedzi, CC Iwuji, ML Newell
Journal of acquired immune deficiency syndromes (1999) 65 (1), e17, 2014
Impact of chromosomal instability on colorectal cancer progression and outcome
B Orsetti, J Selves, C Bascoul-Mollevi, L Lasorsa, K Gordien, F Bibeau, ...
BMC cancer 14 (1), 1-13, 2014
Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal
J Orne-Gliemann, J Larmarange, S Boyer, C Iwuji, N McGrath, ...
BMC public health 15 (1), 1-14, 2015
“It is better to die”: experiences of traditional health practitioners within the HIV treatment as prevention trial communities in rural South Africa (ANRS 12249 TasP trial)
M Moshabela, T Zuma, J Orne-Gliemann, C Iwuji, J Larmarange, ...
Aids Care 28 (sup3), 24-32, 2016
Impact of next-generation sequencing defined human immunodeficiency virus pretreatment drug resistance on virological outcomes in the ANRS 12249 treatment-as-prevention trial
A Derache, CC Iwuji, K Baisley, S Danaviah, AG Marcelin, V Calvez, ...
Clinical Infectious Diseases 69 (2), 207-214, 2019
Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa
CE Oldenburg, T Bärnighausen, F Tanser, CC Iwuji, V De Gruttola, ...
Reviews of Infectious Diseases 63 (4), 548-554, 2016
Universal test and treat is not associated with sub‐optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial
C Iwuji, N McGrath, A Calmy, F Dabis, D Pillay, ML Newell, K Baisley, ...
Journal of the International AIDS Society 21 (6), e25112, 2018
Virological outcomes of second-line protease inhibitor–based treatment for human immunodeficiency virus type 1 in a high-prevalence rural South African setting: a competing …
D Collier, C Iwuji, A Derache, T de Oliveira, N Okesola, A Calmy, F Dabis, ...
Clinical infectious diseases 64 (8), 1006-1016, 2017
Community perceptions of repeat HIV-testing: experiences of the ANRS 12249 Treatment as Prevention trial in rural South Africa
J Orne-Gliemann, T Zuma, J Chikovore, N Gillespie, M Grant, C Iwuji, ...
Aids Care 28 (sup3), 14-23, 2016
The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu‐Natal (South Africa)
J Larmarange, MH Diallo, N McGrath, C Iwuji, M Plazy, R Thiébaut, ...
Journal of the International AIDS Society 21, e25128, 2018
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20